Quantum Cyber vs YD Bio
QUCY and YDES side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How QUCY and YDES compare
YD Bio grew revenue faster over the last twelve months (16.9% versus −39.9% for Quantum Cyber).
YD Bio keeps more of each dollar of sales as profit, with a net margin of −1393% compared with −3018% at Quantum Cyber.
YD Bio scores higher on the StockData Score (5 against 3 for Quantum Cyber), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | QUCY | YDES |
|---|---|---|
| Size and price | ||
| Share price | $0.580 | $4.73 |
| Change, 1 year | −60.3% | −61.4% |
| Change, 5 years | −94.1% | −53.5% |
| Beta (5Y) | 2.15 | −0.59 |
| Employees | 3 | 13 |
| StockData Score | ||
| Total score | 3 | 5 (better) |
| Valuation score | 0 | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | −39.9% | 16.9% (better) |
| Revenue growth, 5Y average | 1.7% | – |
| Profitability | ||
| Gross margin | 72.6% (better) | 28.1% |
| Operating margin | −3005% | −883% (better) |
| Net margin | −3018% | −1393% (better) |
| FCF margin | −2045% | −1347% (better) |
| Return on equity | −141% (better) | −174% |
| Return on invested capital | −324% | −130% (better) |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −43.2× | – |
| Current ratio | 5.56 (better) | 5.23 |
| Piotroski F-score | 2 | 2 |
| Ownership | ||
| Held by institutions | 2.4% | – |
| Held by insiders | – | 92.8% |
| Insider net buying, 12 months | $0 | $129K (better) |
Go deeper
- QUCY stock overview
- QUCY income statement
- QUCY valuation and score
- YDES stock overview
- YDES income statement
- YDES valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.